Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the
roles of fetuin-A, adiponectin, and AMPK.
Authors Ix JH, Sharma K
Submitted By Kumar Sharma on 3/24/2010
Status Published
Journal Journal of the American Society of Nephrology : JASN
Year 2010
Date Published 3/1/2010
Volume : Pages 21(3) : 406 - 412
PubMed Reference 20150538
Abstract Obesity is a risk factor for chronic kidney disease (CKD) and nonalcoholic fatty
liver disease (NAFLD). Recent studies identify mechanisms common to both
diseases linked through an interorgan communication orchestrated by fetuin-A and
adiponectin. In liver and kidney, the energy sensor 5'-AMP activated protein
kinase (AMPK) is pivotal to directing podocytes and hepatocytes to compensatory
and potentially deleterious pathways, leading to inflammatory and profibrotic
cascades culminating in end-organ damage. Regulation of these early upstream
pathways may provide new therapeutic targets for these increasingly common
sequelae of obesity.


Investigators with authorship
NameInstitution
Kumar SharmaUniversity of California San Diego

Complications









Genes
SymbolDescription
Map3k14mitogen-activated protein kinase kinase kinase 14
Adipoqadiponectin, C1Q and collagen domain containing